Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation

被引:259
作者
Nantel, F
Denis, D
Gordon, R
Northey, A
Cirino, M
Metters, KM
Chan, CC
机构
[1] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada
[2] Merck Frosst Ctr Therapeut Res, Dept Pharmacol, Pointe Claire, PQ H9R 4P8, Canada
关键词
prostaglandin; cyclooxygenase; inflammation; antibodies;
D O I
10.1038/sj.bjp.0702866
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We characterized the regulation of cyclooxygenase-2 (COX-2) at the mRNA, protein and mediator level in two rat models of acute inflammation, carrageenan-induced paw oedema and mechanical hyperalgesia. 2 Carrageenan was injected in the hind paw of rat at low (paw oedema) and high doses (hyperalgesia). COX-2 and prostaglandin E-2 (PGE(2)) levels were measured by RT-PCR and immunological assays. We also determined the distribution of COX-2 by immunohistochemistry. 3 The injection of carrageenan produced a significant and parallel induction of both COX-2 and PGE(2). This induction was significantly higher in hyperalgesia than in paw oedema. This was probably due to the 9 fold higher concentration of carrageenan used to provoke hyperalgesia. 4 Immunohistochemical examination showed COX-2 immunoreactivity in the epidermis, skeletal muscle and inflammatory cells of rats experiencing hyperalgesia. In paw oedema however, only the epidermis showed positive COX-2 immunoreactivity. 5 Pretreatment with indomethacin completely abolished the induction of COX-2 in paw oedema but not in hyperalgesia. 6 These results suggest that multiple mechanisms regulate COX-2 induction especially in the more severe model. In carrageenan-induced paw oedema, prostanoid production have been linked through the expression of the COX-2 gene which suggest the presence of a positive feedback loop mechanism.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 36 条
  • [1] ALMEIDA AP, 1980, J PHARMACOL EXP THER, V214, P74
  • [2] Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis
    Anderson, GD
    Hauser, SD
    McGarity, KL
    Bremer, ME
    Isakson, PC
    Gregory, SA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2672 - 2679
  • [3] PROINFLAMMATORY CYTOKINES REGULATE CYCLOOXYGENASE-2, MESSENGER-RNA EXPRESSION IN HUMAN MACROPHAGES
    ARIASNEGRETE, S
    KELLER, K
    CHADEE, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (02) : 582 - 589
  • [4] A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen
    Bjarnason, I
    Macpherson, A
    Rotman, H
    Schupp, J
    Hayllar, J
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (02) : 126 - 130
  • [5] The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-α and leukotriene B4 in a novel human whole blood assay
    Brideau, C
    Van Staden, C
    Styhler, A
    Rodger, IW
    Chan, CC
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (04) : 979 - 988
  • [6] CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531
  • [7] HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT
    FUNK, CD
    FUNK, LB
    KENNEDY, ME
    PONG, AS
    FITZGERALD, GA
    [J]. FASEB JOURNAL, 1991, 5 (09) : 2304 - 2312
  • [8] Meloxicam: Selective COX-2 inhibition in clinical practice
    Furst, DE
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1997, 26 (06) : 21 - 27
  • [9] LIPOPOLYSACCHARIDE INDUCES PROSTAGLANDIN-H SYNTHASE-2 PROTEIN AND MESSENGER-RNA IN HUMAN ALVEOLAR MACROPHAGES AND BLOOD MONOCYTES
    HEMPEL, SL
    MONICK, MM
    HUNNINGHAKE, GW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 391 - 396
  • [10] Prostaglandin synthase 2
    Herschman, HR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1996, 1299 (01): : 125 - 140